The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases

L Rochette, A Meloux, E Rigal, M Zeller, Y Cottin… - Pharmacology & …, 2018 - Elsevier
Among the numerous molecules that are being studied for their potential utility as
biomarkers of cardiovascular diseases, much interest has been shown in the superfamily of …

Biomarkers of inflammation in left ventricular diastolic dysfunction

M Mocan, LD Mocan Hognogi, FP Anton… - Disease …, 2019 - Wiley Online Library
Left ventricular diastolic dysfunction (LVDD) is an important precursor to many different
cardiovascular diseases. Diastolic abnormalities have been studied extensively in the past …

Diabetes mellitus related biomarker: the predictive role of growth-differentiation factor-15

AE Berezin - Diabetes & Metabolic Syndrome: Clinical Research & …, 2016 - Elsevier
Abstract Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine, which
belongs to super family of the transforming growth factor beta. GDF-15 is widely presented in …

Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction

GD Plitt, JT Spring, MJ Moulton… - Expert review of …, 2018 - Taylor & Francis
Introduction: Heart failure with preserved ejection fraction (HFpEF) continues to be a major
challenge for clinicians. Many crucial aspects of the syndrome remain unclear, including the …

A preclinical rat model of heart failure with preserved ejection fraction with multiple comorbidities

G Hubesch, A Hanthazi, A Acheampong… - Frontiers in …, 2022 - frontiersin.org
Heart failure with preserved ejection fraction (HFpEF) is a common complex clinical
syndrome for which there are currently few evidence-based therapies. As patients with …

Cardiac remodeling biomarkers as potential circulating markers of left ventricular hypertrophy in heart failure with preserved ejection fraction

VT Mitic, DR Stojanovic, MZD Ilic… - The Tohoku Journal of …, 2020 - jstage.jst.go.jp
Soluble suppressor of tumorigenicity 2 (sST2), galectin-3, growth differentiation factor (GDF)-
15 and syndecan-1 represent biomarkers of cardiac remodeling, involved in heart failure …

[HTML][HTML] Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction

C Schulte, D Westermann, S Blankenberg… - World journal of …, 2015 - ncbi.nlm.nih.gov
Abstract microRNAs (miRNAs) are powerful regulators of posttranscriptional gene
expression and play an important role in pathophysiological processes. Circulating miRNAs …

The vulnerable right ventricle

S Reddy, D Bernstein - Current opinion in pediatrics, 2015 - journals.lww.com
The purpose of this review is to highlight the differences between the right and left
ventricular responses to stress, our current knowledge of how the RV adapts to the unique …

Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes

L Bobronnikova - 2017 - repo.knmu.edu.ua
Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in
patients with hypertension and type Page 1 © 2017 OAE Publishing Inc. www.oaepublish.com 61 …

Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction

I Gergei, BK Kraemer, H Scharnagl, T Stojakovic… - Peptides, 2019 - Elsevier
Renal dysfunction may limit the clinical application of NT-proBNP in the diagnosis of heart
failure. In general practice, where echocardiography is not readily available, a biomarker for …